BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8044412)

  • 1. Postprandial hyperlipidemia and remnant lipoproteins.
    Havel RJ
    Curr Opin Lipidol; 1994 Apr; 5(2):102-9. PubMed ID: 8044412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
    Björkegren J; Silveira A; Boquist S; Tang R; Karpe F; Bond MG; de Faire U; Hamsten A
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1470-4. PubMed ID: 12231568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study.
    Simons LA; Dwyer T; Simons J; Bernstein L; Mock P; Poonia NS; Balasubramaniam S; Baron D; Branson J; Morgan J
    Atherosclerosis; 1987 May; 65(1-2):181-9. PubMed ID: 3496893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial lipoproteins and progression of coronary atherosclerosis.
    Karpe F; Steiner G; Uffelman K; Olivecrona T; Hamsten A
    Atherosclerosis; 1994 Mar; 106(1):83-97. PubMed ID: 8018110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slower catabolism of apo B48 than of apo B100 in triglyceride-rich lipoproteins during heparin infusions in type 5 hyperlipoproteinemic subjects.
    Nestel P; Billington T
    Metabolism; 1987 Feb; 36(2):172-5. PubMed ID: 3807788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle size of apoB-48 carrying lipoproteins in remnant lipoproteins isolated from postprandial plasma.
    Nakano T; Tanaka A; Okazaki M; Tokita Y; Nagamine T; Nakajima K
    Ann Clin Biochem; 2011 Jan; 48(Pt 1):57-64. PubMed ID: 21098545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
    Karpe F; Hellénius ML; Hamsten A
    Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease.
    Björkegren J; Boquist S; Samnegârd A; Lundman P; Tornvall P; Ericsson CG; Hamsten A
    Circulation; 2000 Jan; 101(3):227-30. PubMed ID: 10645915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.
    Castro Cabezas M; Erkelens DW; Kock LA; De Bruin TW
    Eur J Clin Invest; 1994 Oct; 24(10):669-78. PubMed ID: 7851467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
    Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
    J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway.
    Karpe F; Hultin M
    J Lipid Res; 1995 Jul; 36(7):1557-66. PubMed ID: 7595079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.
    Boquist S; Ruotolo G; Tang R; Björkegren J; Bond MG; de Faire U; Karpe F; Hamsten A
    Circulation; 1999 Aug; 100(7):723-8. PubMed ID: 10449694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.
    Hazzard WR; Kushwaha RS; Applebaum-Bowden D; Haffner SM; Steinmetz A; Foster DM
    Metabolism; 1984 Oct; 33(10):873-81. PubMed ID: 6482732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
    Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
    Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
    Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
    Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.